CPA
ELV icon

Capital Performance Advisors’s Elevance Health ELV Stock Holding History

Capital Performance Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-567
Closed -$247K – 288
2025
Q1 		$247K Buy
+567
New +$228K 0.05% 199
2024
Q4 		– Sell
-42
Closed -$21.9K – 921
2024
Q3 		$21.9K Buy
+42
New +$22.4K 0.01% 584

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Capital Performance Advisors's ELV Position: Q2 2025 in Review

Capital Performance Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 567 shares — an estimated $247K sold.

Capital Performance Advisors first reported a position in ELV in Q3 2024 and held it in 2 quarters. The position peaked at $247K in Q1 2025. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Capital Performance Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Capital Performance Advisors sold 567 Elevance Health shares in Q2 2025, an estimated $247K.
  • Capital Performance Advisors first reported a position in Elevance Health in Q3 2024 and held it in 2 quarters.
  • Capital Performance Advisors's Elevance Health position peaked at $247K in Q1 2025.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Capital Performance Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.